These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report. Seppälä TT; Ahadova A; Dominguez-Valentin M; Macrae F; Evans DG; Therkildsen C; Sampson J; Scott R; Burn J; Möslein G; Bernstein I; Holinski-Feder E; Pylvänäinen K; Renkonen-Sinisalo L; Lepistö A; Lautrup CK; Lindblom A; Plazzer JP; Winship I; Tjandra D; Katz LH; Aretz S; Hüneburg R; Holzapfel S; Heinimann K; Valle AD; Neffa F; Gluck N; de Vos Tot Nederveen Cappel WH; Vasen H; Morak M; Steinke-Lange V; Engel C; Rahner N; Schmiegel W; Vangala D; Thomas H; Green K; Lalloo F; Crosbie EJ; Hill J; Capella G; Pineda M; Navarro M; Blanco I; Ten Broeke S; Nielsen M; Ljungmann K; Nakken S; Lindor N; Frayling I; Hovig E; Sunde L; Kloor M; Mecklin JP; Kalager M; Møller P Hered Cancer Clin Pract; 2019; 17():8. PubMed ID: 30858900 [TBL] [Abstract][Full Text] [Related]
3. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome. Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427 [TBL] [Abstract][Full Text] [Related]
4. CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome. Ahadova A; von Knebel Doeberitz M; Bläker H; Kloor M Fam Cancer; 2016 Oct; 15(4):579-86. PubMed ID: 26960970 [TBL] [Abstract][Full Text] [Related]
5. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers. Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495 [TBL] [Abstract][Full Text] [Related]
6. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study. Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C; BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342 [TBL] [Abstract][Full Text] [Related]
7. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome. Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ; Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173 [TBL] [Abstract][Full Text] [Related]
8. Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy. Lappalainen J; Holmström D; Lepistö A; Saarnio J; Mecklin JP; Seppälä T Scand J Gastroenterol; 2019 Dec; 54(12):1473-1480. PubMed ID: 31829749 [No Abstract] [Full Text] [Related]
9. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers. Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875 [TBL] [Abstract][Full Text] [Related]
10. Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study. Stoffel EM; Erichsen R; Frøslev T; Pedersen L; Vyberg M; Koeppe E; Crockett SD; Hamilton SR; Sørensen HT; Baron JA Gastroenterology; 2016 Nov; 151(5):870-878.e3. PubMed ID: 27443823 [TBL] [Abstract][Full Text] [Related]
11. Implication of DNA repair genes in Lynch-like syndrome. Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
13. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145 [TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer. Carethers JM; Stoffel EM World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352 [TBL] [Abstract][Full Text] [Related]
16. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. Chang K; Taggart MW; Reyes-Uribe L; Borras E; Riquelme E; Barnett RM; Leoni G; San Lucas FA; Catanese MT; Mori F; Diodoro MG; You YN; Hawk ET; Roszik J; Scheet P; Kopetz S; Nicosia A; Scarselli E; Lynch PM; McAllister F; Vilar E JAMA Oncol; 2018 Aug; 4(8):1085-1092. PubMed ID: 29710228 [TBL] [Abstract][Full Text] [Related]
17. Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers. Geurts-Giele WR; Leenen CH; Dubbink HJ; Meijssen IC; Post E; Sleddens HF; Kuipers EJ; Goverde A; van den Ouweland AM; van Lier MG; Steyerberg EW; van Leerdam ME; Wagner A; Dinjens WN J Pathol; 2014 Dec; 234(4):548-59. PubMed ID: 25111426 [TBL] [Abstract][Full Text] [Related]
18. The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. Kang YJ; Killen J; Caruana M; Simms K; Taylor N; Frayling IM; Snowsill T; Huxley N; Coupe VM; Hughes S; Freeman V; Boussioutas A; Trainer AH; Ward RL; Mitchell G; Macrae FA; Canfell K Med J Aust; 2020 Feb; 212(2):72-81. PubMed ID: 31595523 [TBL] [Abstract][Full Text] [Related]
19. Features of incident colorectal cancer in Lynch syndrome. Argillander TE; Koornstra JJ; van Kouwen M; Langers AM; Nagengast FM; Vecht J; de Vos Tot Nederveen Cappel WH; Dekker E; van Duijvendijk P; Vasen HF United European Gastroenterol J; 2018 Oct; 6(8):1215-1222. PubMed ID: 30288284 [TBL] [Abstract][Full Text] [Related]
20. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients. Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]